PD-L1在结直肠癌中的表达及其临床意义  被引量:5

Expression of PD- L1 expression in colorectal cancer and its clinical value

在线阅读下载全文

作  者:李海青 曹猛 江涛 吴兆应 徐溢新 徐为 宋军 

机构地区:[1]徐州医科大学研究生学院,江苏 徐州221004 [2]徐州医科大学附属医院胃肠外科,江苏 徐州221002

出  处:《徐州医科大学学报》2017年第4期227-230,共4页Journal of Xuzhou Medical University

基  金:江苏省研究生科研创新计划(SJLXl5_0723);江苏省“333工程”基金项目(BRA2015505)

摘  要:目的探讨程序性死亡因子配体1(PD-L1)蛋白在结直肠癌组织中的表达及其临床意义。方法运用免疫组织化学方法,检测含90例结直肠癌组织的结直肠癌组织芯片中PD-L1的表达,并结合临床病理资料分析PD-L1的表达与患者预后的关系。结果PD-L1在肿瘤组织中阳性率为81.11%,在正常组织中为42.22%,差异有统计学意义(P〈0.01);PD-L1的表达与肿瘤TNM分期相关(P=0.029),而与年龄、性别、肿瘤大小、病理分化程度无相关性(P〉0.05)。Kaplan-Meier生存曲线分析示,PD-L1低表达组的术后生存时间明显高于高表达组(P〈0.05)。多因素Cox比例风险模型分析表明,PD-L1表达是结直肠癌的独立预后因素之一(P〈0.05)。结论PD-L1可能成为结直肠癌靶向治疗的有效靶点,并可作为判断结直肠癌预后的独立指标。Objective To investigate the expression of programmed death ligand-1(PD-L1) in colorectal cancer and normal coloreetal tissues, and its clinical values. Methods The level of PD-L1 was detected by immunohisto- chemistry staining using a tissue microarray containing 90 eoloreetal cancer tissue samples. Meanwhile, the relationship between PD - L1 expression and patient prognosis was analyzed. Results The positive expression rate of PD - L1 was 81.11%, which was remarkably different from 42.22% in normal tissues (P 〈0. 001 ). The expression of PD -L1 was significantly associated with TNM stages ( P = 0. 029 ) , rather than age, gender, tumor size, and pathological grade ( P 〉 0.05 ). According to the Kaplan - Meier analysis, the survival time was markedly higher in the low PD - L1 expression group than that in the high PD - L1 expression group after operation ( P 〈 0.05 ). The Cox regression model indicated that expression of PD - L1 was an independent prognostic factor for patients with eoloreetal cancer ( P 〈 0.05 ). Conclusion The increased PD - L1 expression in colorectal cancer is associated with poor prognosis. PD - L1 can be a promising treatment target of coloreetal cancer and an independent molecular marker to evaluate the prognosis of patients with color- ectal cancer.

关 键 词:结直肠癌 共刺激分子 程序性死亡因子配体1 预后 

分 类 号:R735.35[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象